We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Innovation Stalls Despite R&D Spending: Report

Law360 (January 4, 2007, 12:00 AM EST) -- The pharmaceutical industry has been dragging its feet in developing new drugs even as it pours more cash into research efforts, according to a government report.

The number of new medicines to receive the green light from U.S. regulators reached nearly an eight-year low in 2006, while the number of medicines recommended for sale in 2006 and 2005 fell from the annual average of 26 drugs recorded in the previous six years, Bloomberg News reported on Thursday, citing U.S. data.

But while drug innovation slumped, the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.